Equinor ASA Form 6-K Summary: Q4 and Full Year 2019 Results
Business Context and Reporting Period
This Form 6-K, filed on February 6, 2020, reports Equinor ASA's financial results for the fourth quarter and full year ended December 31, 2019. The period was characterized by lower commodity prices, record-high production volumes, and the successful early start-up of the Johan Sverdrup field. The company also highlighted significant progress in its renewables portfolio, including major offshore wind projects in the UK and US.
Key Financial Metrics
| Metric | Q4 2019 | Q4 2018 | Full Year 2019 | Full Year 2018 |
|---|---|---|---|---|
| Adjusted Earnings (USD bn) | 3.55 | 4.39 | 13.5 | 18.0 |
| Adjusted Earnings After Tax (USD bn) | 1.19 | 1.54 | 4.93 | 6.69 |
| IFRS Net Operating Income (USD bn) | 1.52 | 6.75 | 9.30 | 20.14 |
| IFRS Net Income (USD bn) | (0.23) | 3.37 | 1.85 | 7.54 |
| Total Equity Production (mboe/day) | 2,198 | 2,170 | 2,074 | 2,111 |
| Organic Capex (USD bn) | N/A | N/A | 10.0 | N/A |
| Net Debt to Capital Employed (%) | 23.8% | 22.2% | 23.8% | 22.2% |
| Free Cash Flow (USD bn) | (0.51) | 0.64 | (0.18) | 3.13 |
Note: Q4 2019 IFRS Net Income was negative due to net impairment charges of USD 1.41 billion, primarily related to assets on the Norwegian continental shelf.
Material Changes vs. Prior Period
- Revenue and Earnings: Adjusted earnings declined 19% in Q4 and 25% for the full year compared to 2018, driven primarily by lower average prices for liquids and gas. IFRS net operating income dropped 78% in Q4 and 54% for the full year.
- Impairments: Significant net impairment charges of USD 1.41 billion in Q4 and USD 4.10 billion for the full year negatively impacted IFRS results. These were largely due to changes in accounting methods for tax uplift in impairment evaluations and lower short-term gas price assumptions.
- Production: Total equity production reached a record high of 2,198 mboe/day in Q4 2019, up 1% year-over-year, driven by the ramp-up of Johan Sverdrup and new fields in the US and UK.
- Costs: Adjusted operating and administrative expenses decreased 8% in Q4 compared to the prior year, reflecting cost discipline and the impact of the NOK/USD exchange rate.
Guidance, Outlook, and Management Commentary
- Production Growth: Equinor expects approximately 7% production growth in 2020 and an average annual growth of around 3% from 2019 to 2026.
- Capital Expenditure: Organic capex is estimated at USD 10-11 billion annually for 2020-2021 and around USD 12 billion for 2022-2023.
- Renewables: The company aims to reach carbon neutral global operations by 2030 and reduce net carbon intensity by at least 50% by 2050. Renewables projects in development are expected to add 2.8 GW of capacity, with a target of 4-6 GW by 2026.
- Capital Distribution: The board proposed a 4% increase in the quarterly dividend to USD 0.27 per share. Additionally, Equinor launched a second tranche of its USD 5 billion share buy-back program, subject to shareholder approval.
- Outlook Risks: Key risks include commodity price volatility, timing of new capacity, operational regularity, and uncertainty regarding the closing of announced transactions.
Investor Verification Checklist
- Impairment Details: Verify the specific impact of the USD 1.41 billion Q4 impairment charge on future depreciation and asset valuations, particularly regarding the change in tax uplift methodology.
- Free Cash Flow: Confirm the drivers behind the negative free cash flow in Q4 and the full year, specifically the impact of derivative payments and share buy-backs versus operating cash generation.
- Renewables Execution: Monitor the progress and capital requirements for the Dogger Bank and Empire Wind projects to ensure they meet the 2026 capacity targets.
- Dividend and Buyback: Track the approval status of the proposed dividend increase and the second tranche of the share buy-back program at the Annual General Meeting.
- Legal Contingencies: Review the status of the Agbami field redetermination in Nigeria (USD 853 million provision) and the ICMS tax dispute in Brazil (approx. USD 700 million exposure).